| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Description:
Rivaroxaban
Rivaroxaban is an oral anticoagulant medication that belongs to the class of direct oral anticoagulants (DOACs). It is a selective inhibitor of Factor Xa, an enzyme crucial in the blood clotting process. Available in tablet form, Rivaroxaban provides consistent and predictable anticoagulation with fewer dietary restrictions and no routine monitoring requirements. Our Rivaroxaban is manufactured to the highest standards to ensure efficacy, safety, and quality.
Function:
Inhibition of Factor Xa: Rivaroxaban works by selectively inhibiting Factor Xa, an essential enzyme in the coagulation cascade responsible for converting prothrombin to thrombin. By blocking Factor Xa, Rivaroxaban prevents the formation of fibrin clots, reducing the risk of thromboembolic events.
Oral Anticoagulant: As an oral anticoagulant, Rivaroxaban provides a non-invasive option for managing blood clotting disorders, offering convenience and ease of use compared to injectable anticoagulants.
Consistent Anticoagulation: Rivaroxaban provides consistent anticoagulation with predictable pharmacokinetics and pharmacodynamics. This results in stable blood levels, reducing the need for frequent dose adjustments and monitoring.
Rapid Onset and Offset: Rivaroxaban has a rapid onset of action, providing effective anticoagulation within hours of administration. It also has a relatively short half-life, allowing for quick reversal of effects if necessary.
Application:
Prevention of Stroke and Systemic Embolism: Rivaroxaban is indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, a common heart rhythm disorder that increases the risk of blood clots forming in the heart.
Treatment and Prevention of Deep Vein Thrombosis (DVT): It is used to treat DVT, a condition where blood clots form in the deep veins, usually in the legs. Rivaroxaban also helps prevent the recurrence of DVT after an initial episode.
Treatment and Prevention of Pulmonary Embolism (PE): Rivaroxaban is effective in treating PE, a potentially life-threatening condition where a blood clot travels to the lungs. It also helps prevent recurrent PE.
Prevention of Venous Thromboembolism (VTE): It is used for the prevention of VTE in patients undergoing major orthopedic surgeries, such as hip or knee replacement, where the risk of blood clots is increased.
Prevention of Cardiovascular Events: Rivaroxaban may be used in combination with aspirin to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
Long-Term Management: Due to its favorable safety profile and lack of need for routine monitoring, Rivaroxaban is suitable for long-term management of patients at risk of thromboembolic events.
Reduced Dietary and Drug Interactions: Rivaroxaban has fewer dietary restrictions and drug interactions, allowing for more flexibility in patient management and adherence.
Convenient Dosing: Rivaroxaban is taken once or twice daily, depending on the indication, providing a convenient dosing schedule that enhances patient compliance.
){kind=link}